Диссертация (1174357), страница 23
Текст из файла (страница 23)
Современные представления о гиперплазии эндометрия /Г.Е. Чернуха, М.Р. Думановская // Акушерство и гинекология. – 2013. – № 3. -С.26-32.107. Чумаков,П.М.Белокр53иегоуниверсальныефункциивмногоклеточном организме / П.М. Чумаков // Успехи биологической химии. –2007. – № 47. – С. 3-52.108. Шапиевский, Б.М. Дифференцированный выбор метода лечениягиперпластических процессов эндометрия в перименопаузальном периоде :автореф. дисс. … канд. мед.
наук / Б.М. Шапиевский. – М., 2009. – 25 с.109. Шешукова, Н.А., Макаров И.О. Оценка функционального статусаслизистой оболочки тела матки у пациенток с гиперпластическими процессамиэндометрия / Н.А. Шешукова, И.О. Макаров // Акушерство и гинекология. –2012. – № 2. – С. 72-75.110. Шигорева, Т. В. Клинико-морфологические аспекты внутриматочноговоздействия левоноргестрела при гиперплазии эндометрия : дис. … канд. мед.наук: 14.00.01 : защищена 11.11.08 / Т. В. Шигорева. – М., 2008.
– 208 с.111. Ярилин, А.А. Апоптоз: природа феномена и его роль в норме и припатологии. В кн.: Актуальные проблемы патофизиологии / Под ред. Б.Б. Мороз. –М. : Медицина, 2001. – С. 13-56.112. AAGL practice report: practice guidelines for the diagnosis and managementof endometrial polyps / American Association of Gynecologic Laparoscopists // J.Minim.
Invasive Gynecol. – 2012. – Vol. 19 (1). – Р. 3-10.113. Absolute risk of endometrial carcinoma during 20-year follow-up amongwomen with endometrial hyperplasia / J.V. Lacey [et al.] // J. Clin. Oncol. – 2010. –Vol. 28 (5). – Р. 788-792.114. Adipose tissue and adipocytes support tumorigenesis and metastasis / K.M.Nieman [et al.] // Biochim. Biophys. Acta. – 2013. – Vol. 1831 (10). – Р. 1533-1541.150115. Ali, A.T. Reproductive factors and the risk of endometrial cancer / A.T. Ali// Int. J. Gynecol. Cancer. – 2014. – Vol. 24 (3).
– P. 384-393.116. AlteredexpressionofERs,aromatase,andCOX2connectedto estrogen action in type 1 endometrial cancer biology / K. Jarzabek [et al.] // TumourBiol. – 2013. – Vol. 34 (6). – P. 4007-4016.117. Amalinei, C. Morphogenesis and differentiation of the female genital tract.Genetic determinism and epitheliumstromal interactions /C. Amalinei // Rev. Med.Chir. Soc.
Med. Nat. Iasi. – 2007. – Vol. 111 (1). – P. 200-209.118. Analysis of estrogen- and progesterone-receptor expression in endometrialpolyps / R.G. Lopes [et al.] // J. Minim. Invasive Gynecol. – 2007. – Vol. 14 (3). – P.300-303.119. Analysis of PTEN, estrogen receptor б and progesterone receptor expressionin endometrial hyperplasia using tissue microarray / B. Pieczyńska [et al.] // Pol.
J.Pathol. – 2011. – Vol. 62 (3). – P. 133-138.120. Androgen receptor expression in estrogen receptor-negative breast cancer.Immunohistochemical, clinical, and prognostic associations / S.N. Agoff [et al.] // Am.J. Clin. Pathol. – 2003. – Vol. 120 (5). – P. 725-731.121. Apoptosis may be an early event of progestin therapy for endometrialhyperplasia / C.A. Amezcua [et al.] // Gynecol. Oncol. – 2000. – Vol. 79 (2). – P.
169176.122. Apoptosis-related proteins and steroid hormone receptors in normal,hyperplastic and neoplastic endometrium / O. Bozdogan [et al.] // Int. J. Gynecol.Pathol. – 2002. – Vol. 21 (4) – P. 375-382.123. Are the site, diameter, and number of endometrial polyps related withsymptomatology? / H. Hassa [et al.] // Am. J. Obstet.
Gynecol. – 2006. – Vol. 194 (3). –P. 718-721.124. A randomized, double-blind, placebo-controlled,multicenter study thatassessed the endometrial effects of norethindrone acetate plus ethinyl estradiolversusethinyl estradiol alone / D.J. Portman [et al.] // Am. J. Obstet. Gynecol. – 2003. – Vol.188 (2). – P. 334-342.151125. A review of trafficking and activation of uterine natural killer cells / M. J.van den Heuvel [et al.] // Am. J. Reprod. Immunol. – 2005.
– Vol. 54. – P. 322-331.126. Assessment of the risk on endometrial cancer in hyperplasia, by means ofmorphological and morphometrical features / J.P. Baak [et al.] // Pathol. Res. Pract.1992. – Vol. 188 (7). – P. 856-859.127. Association between diabetes, diabetes treatment and risk of developingendometrial cancer / J. Luo [et al.] // Br. J. Cancer.
– 2014. – Vol. 111 (7). – P. 14321439.128. Association of the apolipoprotein E 2 allele with concurrent occurrence ofendometrial hyperplasia and endometrial carcinoma / T.I. Ivanova [et al.] // Oxid. Med.Cell. Longev. – 2015. – Vol. 2015. – P. 593658.129. A transmembrane intracellular estrogen receptor mediates rapid cellsignaling / C.M. Revankar [et al.] // A Science. – 2005. – Vol. 307 (5715). – P. 16251630.130. Baban, R.S. Prolactin receptors in uterine leiomyomas / R.S.
Baban, S.T. AlZuheiri, Y.Y. Farid // Saudi Med. J. – 2008. – Vol. 29 (11). – P. 1593-1596.131. Ball, H.J. Endometrial cancer: current concepts and management / H.J. Ball,E.A. Elkardy // Surg. Oncol. Clin. N. Am. – 1998. – Vol. 7 (2). – P. 271-284.132. Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dosegestagen therapy: a comparison of responses in patients treated with intrauterinelevonorgestrel and systemic medroxyprogesterone / A.B.
Vereide [et al.] // Gynecol.Oncol. – 2005. – Vol. 97 (3). – P. 740-750.133. Berek and Hacker's. Gynecologic Oncology, 5th edition / J.S. Berek, N.F.Hacker. – Lippincott Williams & Wilkins, 2009. – 912 p.134. Bernichtein, S. New concepts in prolactin biology / S. Bernichtein, P.Touraine, V. Goffin // J. Endocrinol. – 2010. – Vol.
206 (1). – Р. 1-11.135. beta-Catenin mutations and aberrant nuclear expression during endometrialtumorigenesis / M. Saegusa [et al.] // Br. J. Cancer. – 2001. – Vol. 84 (2). – P. 209-217.152136. Brandebourg, T. Adipocyte prolactin: regulation of release and putativefunctions / T. Brandebourg, E. Hugo, N. Ben-Jonathan // Diabetes Obes. Metab. – 2007.– Vol. 9 (4). – P. 464–476.137. Brown, K. Is tamoxifen a genotoxic carcinogen in women? / K.
Brown //Mutagenesis. – 2009. – Vol. 24 (5). – P. 391-404.138. Bruchim, I. The IGF hormonal network in endometrial cancer: functions,regulation, and targeting approaches / I. Bruchim, R. Sarfstein, H. Werner // Front.Endocrinol. (Lausanne). – 2014. – Vol. 5. – P. 76.139.
Cancer incidence and mortality worldwide: Sources, methods and majorpatterns in GLOBOCAN 2012 / J. Ferlay [et al.] // International Journal of Cancer. –2014. – Vol. 136 (5). – P. E359-E386.140. Caringella, A.M. Clinical function of estrogen receptors in endometrialcancer / A.M.
Caringella, E. Di Naro, G. Loverro // Minerva Ginecol. – 2011. – Vol. 63(6). – P. 495-504.141. Catch it before it kills: progesterone, obesity, and the prevention ofendometrial cancer / M.J. Carlson [et al.] // Discov. Med. – 2012. – Vol. 14 (76). –P.215-222.142. Chapman, H.A.
Plasminogen activators, integrins, and the coordinatedregulation of cell adhesion and migration / H.A. Chapman // Curr. Opin. Cell Biol. –1997. – Vol. 9 (5). – P. 714-724.143. Choudhry, M.A. 17β-Estradiol: a novel hormone for improving immune andcardiovascular responses following trauma-hemorrhage / M.A. Choudhry, I.H. Chaudry// J. Leukoc. Biol. – 2008. – Vol. 83 (3). – P. 518-522.144. Clinical and pathological correlations in endometrial pathology / R.E.Bohîlțea [et al.] // J. Med.
Life. – 2015. – Vol. 8 (4). – P. 552-562.145. Clinical over- and under-estimation in patients who underwent hysterectomyfor atypical endometrial hyperplasia diagnosed by endometrial biopsy: the predictivevalue of clinical parameters and diagnostic imaging / T. Kimura [et al.] // Eur. J.Gynecol. Reprod. Biol. – 2003. – Vol. 108 (2). – P. 213-216.153146. Cohen-Becker I.R. Hyperprolactinemia alters the frequency and amplitudeof pulsatile luteinizing hormone secretion in the ovariectomized rat / I.R. CohenBecker, M. Selmanoff, P.M.
Wise // Neuroendocrinology. – 1986. – Vol. 42 (4). – P.328-333.147. Comparison of the efficacy of micronized progesterone and lynestrenol intreatment of simple endometrial hyperplasia without atypia / Y. Tasci [et al.] // Arch.Gynecol. Obstet. – 2014. – Vol. 290 (1). – P. 83-86.148. Comparison of the efficacy of three progestins in the treatment of simpleendometrial hyperplasia without atypia / O. Ozdegirmenci [et al.] // Gynecol. Obstet.Invest.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
